ATYR · All filings · Read this filing
What changed 10-Q
Item 5. Other Information
2024-11-07 compared with 2024-08-13 · 3 added, 2 removed, 50 unchanged (9% of the section changed)
22 unchanged sentences
aTyr Pharma, Inc.
−Removed: 2015 Stock Option and Incentive Plan, as amended
+Added: Non-Qualified Option Agreement for Non-Plan Inducement Grant
+Added: August 13, 2024
Certification of Principal Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
19 unchanged sentences
aTyr Pharma, Inc.
−Removed: August 13, 2024
+Added: November 7, 2024
/s/ Sanjay S.
5 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.